Home Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research
 

Keywords :   


Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research

2016-01-18 00:05:01| Biotech - Topix.net

The firm set a "buy" rating and a $130.00 price target on the biopharmaceutical company's stock. Standpoint Research's price target points to a potential upside of 26.14% from the stock's previous close.

Tags: research coverage receives analysts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
More »